These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8211809)

  • 21. [Prognosis of return to work after streptokinase-treated acute myocardial infarction].
    Christensen JH; Ravn L; Rasmussen SE; Sørensen HT
    Ugeskr Laeger; 1996 Nov; 158(46):6620-2. PubMed ID: 8966830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The body oxygen allowance in myocardial infarct patients with progressive forms of acute circulatory failure].
    Iaremenko OB
    Vrach Delo; 1990 Aug; (8):4-7. PubMed ID: 2256283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The clinical aspects of thrombolytic therapy with streptokinase in myocardial infarct].
    Kharash LM; Gol'dkhammer EI; Abinader EG
    Ter Arkh; 1996; 68(12):53-7. PubMed ID: 9054042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolytic therapy for women in myocardial infarction. Different prognosis?
    Morais J
    Rev Port Cardiol; 1999; 18 Suppl 3():III27-30. PubMed ID: 10574020
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of acetylsalicylic acid and streptokinase on the restoration of systolic heart function in patients after a myocardial infarct].
    Chubuchna II
    Lik Sprava; 1997; (6):48-52. PubMed ID: 9589926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Does intracoronary thrombolytic therapy in myocardial infarct improve left ventricular function?].
    Widimský P; Cervenka V; Gregor P; Sládková T; Dvorák J; Hrdlicka S; Vísek V
    Vnitr Lek; 1985 May; 31(5):430-40. PubMed ID: 4024488
    [No Abstract]   [Full Text] [Related]  

  • 27. [Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction].
    Perepech NB; Nedoshivin AO; Kutuzova AE
    Klin Med (Mosk); 1993 Jan; 71(1):19-22. PubMed ID: 8046897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peripheral circulatory and tissue oxygen regimen functions in acute myocardial infarct patients being treated with obzidan].
    Parkhomenko AN; Iaremenko OB
    Vrach Delo; 1986 Feb; (2):41-4. PubMed ID: 3705566
    [No Abstract]   [Full Text] [Related]  

  • 29. [Phosphocreatine in the treatment of patients with myocardial infarct: effects on hemodynamics and oxygen supply].
    Perepech NB; Saks VA; Nedoshivin AO; Kutuzova AE; Alisova NP
    Kardiologiia; 1990 Oct; 30(10):52-5. PubMed ID: 2290272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Initial experience with using phosphocreatine in patients in the early (up to 6 hours) period of myocardial infarction].
    Samarenko MB; Afonskaia NI; Dvoskina IS; Ruda MIa
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):75-81. PubMed ID: 3426824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Can intracoronary thrombolytic therapy have an effect on the incidence of complications after myocardial infarct?].
    Cervenka V; Widimský P; Gregor P; Sládková T; Dvorák J; Hrdlicka S; Vísek V
    Vnitr Lek; 1986 Jul; 32(7):625-32. PubMed ID: 3739253
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemodynamic variants of the acute period of uncomplicated myocardial infarct and the trends in their drug therapy].
    Golovtsev IuIu
    Vrach Delo; 1982 Jul; (7):32-6. PubMed ID: 7135899
    [No Abstract]   [Full Text] [Related]  

  • 33. Hemodynamic monitoring and vasodilator therapy in acute left ventricular failure. Preliminary report on a new vasodilator, tolmesoxide.
    Mullie A; Lust P; Nievel J; Penninckx J; Vanhove L; Van Hoonacker G; Vendevelde K; Fenwick J; Coghill J
    Acta Anaesthesiol Belg; 1980; 31 Suppl():147-54. PubMed ID: 7457056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of nitroglycerin on intracardiac hemodynamics in the acute period of myocardial infarct].
    Vongvichit E; Boiarshin SV; Darvish el-A
    Vrach Delo; 1982 Jan; (1):38-41. PubMed ID: 6803441
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thrombolytic therapy in the course of myocardial infarction].
    Klugmann S; Barbieri L; Salvi A; Camerini F
    Cardiologia; 1987 Nov; 32(11):1493. PubMed ID: 3447713
    [No Abstract]   [Full Text] [Related]  

  • 36. [Noninvasive determination of hemodynamic variants of acute myocardial infarction (echocardiography and integral rheography)].
    Serebrennikov VA; Kheĭnonen IM
    Ter Arkh; 1982; 54(3):58-62. PubMed ID: 7089889
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical course of acute myocardial infarction].
    Genth K; Frank J; Langhans ; Schaefer J; Wegwart R; Weinel B; Heene D
    Med Welt; 1980 Jun; 31(26):973-7. PubMed ID: 7421530
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of patients with myocardial infarct and hyperdynamic syndrome with propranolol].
    Golikov AP; Riabinin VA; Polumiskov VIu; Berestov AA
    Kardiologiia; 1983 Sep; 23(9):24-9. PubMed ID: 6645186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of strophathin and rausedil in the 1st days of uncomplicated myocardial infarct].
    Golovtsev IuIu
    Vrach Delo; 1979 Jun; (6):9-12. PubMed ID: 382631
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of Meldonium in Early Postmyocardial Infarction Period].
    Nechaeva GI; Zheltikova EN
    Kardiologiia; 2015; 55(8):35-42. PubMed ID: 26761970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.